CareDx (CDNA) vs Concentra Group Parent (CON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
CareDx (CDNA) has outperformed Concentra Group Parent (CON) over the past year, gaining 329.7% versus a gain of 73.7%. Concentra Group Parent is the larger company by market cap ($4.64 billion vs $3.26 billion), about 1.4 times the size. On valuation, Concentra Group Parent trades at a lower forward P/E (19.8x vs 48.9x for CareDx).
Concentra Group Parent pays a dividend yielding 0.69%, while CareDx does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDNA | CON |
|---|---|---|
| Share price | $63.04 | $36.40 |
| Market cap | $3.26B | $4.64B |
| 1-day change | -1.18% | 0.00% |
| YTD return | +234.61% | +84.96% |
| 1-year return | +329.72% | +73.66% |
| 5-year return | -11.21% | — |
| P/E ratio (TTM) | 30.31 | 23.48 |
| Forward P/E | 48.87 | 19.77 |
| EPS (TTM) | $2.08 | $1.55 |
| Dividend yield | 0.00% | 0.69% |
| Annual dividend | $0.00 | $0.25 |
| Revenue (latest FY) | — | $2.16B |
| Revenue growth (YoY) | — | +13.85% |
| Net income (latest FY) | — | $166.41M |
| Gross margin | — | 28.34% |
| Operating margin | — | 15.44% |
| Net margin | — | 7.69% |
| 52-week high | $72.51 | $36.83 |
| 52-week low | $13.95 | $18.55 |
| Distance from 52-week high | -13.06% | -1.17% |
| Analyst consensus | buy | none |
| Avg. price target upside | -6.68% | +12.64% |
| Average volume | 1.28M | 912.62K |
| Shares outstanding | 51.73M | 127.52M |
| Employees | 761 | 9,967 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CDNA has outperformed CON by 256.1 percentage points over the past year.
- CareDx trades at a higher earnings multiple (30.3x vs 23.5x trailing P/E).
About CareDx
CDNA stock →CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
Health Care · Medical Specialities · 761 employees
About Concentra Group Parent
CON stock →Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.
Health Care · Medical Specialities · 9,967 employees
CDNA vs CON FAQ
Which is bigger, CareDx or Concentra Group Parent?
Concentra Group Parent (CON) is larger, with a market capitalization of $4.64B compared with $3.26B for CareDx (CDNA).
Which stock has performed better over the past year, CDNA or CON?
CDNA returned +329.72% over the past 12 months, compared with +73.66% for CON (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CDNA or CON?
CON has the lower trailing P/E at 23.5, versus 30.3 for CDNA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CareDx or Concentra Group Parent?
Concentra Group Parent pays a dividend yielding 0.69%, while CareDx does not currently pay a regular dividend.
Are CareDx and Concentra Group Parent in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.